Oral, mouse: LD50 = 350 mg/kg; Oral, rat: LD50 = 250 mg/kg
Niflumic acid is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amlodipine | Niflumic acid may decrease the antihypertensive activities of Amlodipine. |
| Phentermine | The risk or severity of hypertension can be increased when Phentermine is combined with Niflumic acid. |
| Midodrine | The risk or severity of hypertension can be increased when Midodrine is combined with Niflumic acid. |
| Eletriptan | The risk or severity of hypertension can be increased when Eletriptan is combined with Niflumic acid. |
| Isoetharine | The risk or severity of hypertension can be increased when Isoetharine is combined with Niflumic acid. |
| Ziprasidone | The risk or severity of hypertension can be increased when Ziprasidone is combined with Niflumic acid. |
| Methysergide | The risk or severity of hypertension can be increased when Methysergide is combined with Niflumic acid. |
| Cabergoline | The risk or severity of hypertension can be increased when Cabergoline is combined with Niflumic acid. |
| Zolmitriptan | The risk or severity of hypertension can be increased when Zolmitriptan is combined with Niflumic acid. |
| Dihydroergotamine | The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Niflumic acid. |
| Methylergometrine | The risk or severity of hypertension can be increased when Methylergometrine is combined with Niflumic acid. |
| Norepinephrine | The risk or severity of hypertension can be increased when Norepinephrine is combined with Niflumic acid. |
| Mirtazapine | The risk or severity of hypertension can be increased when Mirtazapine is combined with Niflumic acid. |
| Phenylephrine | The risk or severity of hypertension can be increased when Phenylephrine is combined with Niflumic acid. |
| Phenylpropanolamine | The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Niflumic acid. |
| Promazine | The risk or severity of hypertension can be increased when Promazine is combined with Niflumic acid. |
| Methylphenidate | The risk or severity of hypertension can be increased when Methylphenidate is combined with Niflumic acid. |
| Droperidol | The risk or severity of hypertension can be increased when Droperidol is combined with Niflumic acid. |
| Doxapram | The risk or severity of hypertension can be increased when Doxapram is combined with Niflumic acid. |
| Atropine | The risk or severity of hypertension can be increased when Atropine is combined with Niflumic acid. |
| Lisuride | The risk or severity of hypertension can be increased when Lisuride is combined with Niflumic acid. |
| Linezolid | The risk or severity of hypertension can be increased when Linezolid is combined with Niflumic acid. |
| Metaraminol | The risk or severity of hypertension can be increased when Metaraminol is combined with Niflumic acid. |
| Furazolidone | The risk or severity of hypertension can be increased when Furazolidone is combined with Niflumic acid. |
| Epinephrine | The risk or severity of hypertension can be increased when Epinephrine is combined with Niflumic acid. |
| Thioridazine | The risk or severity of hypertension can be increased when Thioridazine is combined with Niflumic acid. |
| Ergotamine | The risk or severity of hypertension can be increased when Ergotamine is combined with Niflumic acid. |
| Nicergoline | The risk or severity of hypertension can be increased when Nicergoline is combined with Niflumic acid. |
| Sufentanil | The risk or severity of hypertension can be increased when Sufentanil is combined with Niflumic acid. |
| Methoxamine | The risk or severity of hypertension can be increased when Methoxamine is combined with Niflumic acid. |
| Risperidone | The risk or severity of hypertension can be increased when Risperidone is combined with Niflumic acid. |
| Tranylcypromine | The risk or severity of hypertension can be increased when Tranylcypromine is combined with Niflumic acid. |
| Isoflurane | The risk or severity of hypertension can be increased when Isoflurane is combined with Niflumic acid. |
| Propiomazine | The risk or severity of hypertension can be increased when Propiomazine is combined with Niflumic acid. |
| Alfentanil | The risk or severity of hypertension can be increased when Alfentanil is combined with Niflumic acid. |
| Minaprine | The risk or severity of hypertension can be increased when Minaprine is combined with Niflumic acid. |
| Orciprenaline | The risk or severity of hypertension can be increased when Orciprenaline is combined with Niflumic acid. |
| Phenmetrazine | The risk or severity of hypertension can be increased when Phenmetrazine is combined with Niflumic acid. |
| Trifluoperazine | The risk or severity of hypertension can be increased when Trifluoperazine is combined with Niflumic acid. |
| Pseudoephedrine | The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Niflumic acid. |
| Benzphetamine | The risk or severity of hypertension can be increased when Benzphetamine is combined with Niflumic acid. |
| Ritodrine | The risk or severity of hypertension can be increased when Ritodrine is combined with Niflumic acid. |
| Flupentixol | The risk or severity of hypertension can be increased when Flupentixol is combined with Niflumic acid. |
| Remifentanil | The risk or severity of hypertension can be increased when Remifentanil is combined with Niflumic acid. |
| Bitolterol | The risk or severity of hypertension can be increased when Bitolterol is combined with Niflumic acid. |
| Oxymetazoline | The risk or severity of hypertension can be increased when Oxymetazoline is combined with Niflumic acid. |
| Diethylpropion | The risk or severity of hypertension can be increased when Diethylpropion is combined with Niflumic acid. |
| Salmeterol | The risk or severity of hypertension can be increased when Salmeterol is combined with Niflumic acid. |
| Naratriptan | The risk or severity of hypertension can be increased when Naratriptan is combined with Niflumic acid. |
| Frovatriptan | The risk or severity of hypertension can be increased when Frovatriptan is combined with Niflumic acid. |
| Methoxyflurane | The risk or severity of hypertension can be increased when Methoxyflurane is combined with Niflumic acid. |
| Selegiline | The risk or severity of hypertension can be increased when Selegiline is combined with Niflumic acid. |
| Ergoloid mesylate | The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Niflumic acid. |
| Isoprenaline | The risk or severity of hypertension can be increased when Isoprenaline is combined with Niflumic acid. |
| Arbutamine | The risk or severity of hypertension can be increased when Arbutamine is combined with Niflumic acid. |
| Dutasteride | The risk or severity of hypertension can be increased when Dutasteride is combined with Niflumic acid. |
| Halothane | The risk or severity of hypertension can be increased when Halothane is combined with Niflumic acid. |
| Moclobemide | The risk or severity of hypertension can be increased when Moclobemide is combined with Niflumic acid. |
| Pergolide | The risk or severity of hypertension can be increased when Pergolide is combined with Niflumic acid. |
| Desflurane | The risk or severity of hypertension can be increased when Desflurane is combined with Niflumic acid. |
| Bromocriptine | The risk or severity of hypertension can be increased when Bromocriptine is combined with Niflumic acid. |
| Finasteride | The risk or severity of hypertension can be increased when Finasteride is combined with Niflumic acid. |
| Aripiprazole | The risk or severity of hypertension can be increased when Aripiprazole is combined with Niflumic acid. |
| Isocarboxazid | The risk or severity of hypertension can be increased when Isocarboxazid is combined with Niflumic acid. |
| Ergometrine | The risk or severity of hypertension can be increased when Ergometrine is combined with Niflumic acid. |
| Lisdexamfetamine | The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Niflumic acid. |
| Fenoterol | The risk or severity of hypertension can be increased when Fenoterol is combined with Niflumic acid. |
| Pirbuterol | The risk or severity of hypertension can be increased when Pirbuterol is combined with Niflumic acid. |
| Ephedra sinica root | The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Niflumic acid. |
| Ephedrine | The risk or severity of hypertension can be increased when Ephedrine is combined with Niflumic acid. |
| Mephentermine | The risk or severity of hypertension can be increased when Mephentermine is combined with Niflumic acid. |
| Procaterol | The risk or severity of hypertension can be increased when Procaterol is combined with Niflumic acid. |
| Yohimbine | The risk or severity of hypertension can be increased when Yohimbine is combined with Niflumic acid. |
| Methotrimeprazine | The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Niflumic acid. |
| Clenbuterol | The risk or severity of hypertension can be increased when Clenbuterol is combined with Niflumic acid. |
| Bambuterol | The risk or severity of hypertension can be increased when Bambuterol is combined with Niflumic acid. |
| MMDA | The risk or severity of hypertension can be increased when MMDA is combined with Niflumic acid. |
| Midomafetamine | The risk or severity of hypertension can be increased when Midomafetamine is combined with Niflumic acid. |
| 2,5-Dimethoxy-4-ethylamphetamine | The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Niflumic acid. |
| 4-Methoxyamphetamine | The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Niflumic acid. |
| 4-Bromo-2,5-dimethoxyamphetamine | The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Niflumic acid. |
| Tenamfetamine | The risk or severity of hypertension can be increased when Tenamfetamine is combined with Niflumic acid. |
| Chlorphentermine | The risk or severity of hypertension can be increased when Chlorphentermine is combined with Niflumic acid. |
| Dextroamphetamine | The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Niflumic acid. |
| Phendimetrazine | The risk or severity of hypertension can be increased when Phendimetrazine is combined with Niflumic acid. |
| Solifenacin | The risk or severity of hypertension can be increased when Solifenacin is combined with Niflumic acid. |
| Periciazine | The risk or severity of hypertension can be increased when Periciazine is combined with Niflumic acid. |
| Acepromazine | The risk or severity of hypertension can be increased when Acepromazine is combined with Niflumic acid. |
| Thioproperazine | The risk or severity of hypertension can be increased when Thioproperazine is combined with Niflumic acid. |
| Zuclopenthixol | The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Niflumic acid. |
| Epicaptopril | The risk or severity of hypertension can be increased when Epicaptopril is combined with Niflumic acid. |
| Clorgiline | The risk or severity of hypertension can be increased when Clorgiline is combined with Niflumic acid. |
| 1-benzylimidazole | The risk or severity of hypertension can be increased when Niflumic acid is combined with 1-benzylimidazole. |
| Iproniazid | The risk or severity of hypertension can be increased when Niflumic acid is combined with Iproniazid. |
| Nialamide | The risk or severity of hypertension can be increased when Niflumic acid is combined with Nialamide. |
| Lysergic acid diethylamide | The risk or severity of hypertension can be increased when Niflumic acid is combined with Lysergic acid diethylamide. |
| Dronedarone | The risk or severity of hypertension can be increased when Niflumic acid is combined with Dronedarone. |
| Flibanserin | The risk or severity of hypertension can be increased when Niflumic acid is combined with Flibanserin. |
| Iloperidone | The risk or severity of hypertension can be increased when Niflumic acid is combined with Iloperidone. |
| Indacaterol | The risk or severity of hypertension can be increased when Niflumic acid is combined with Indacaterol. |